Treating older adults requires careful judgment. Age brings changes in muscle mass, medication sensitivity, and other health conditions that affect safety and daily functioning. The study’s findings offer evidence clinicians can use when weighing benefits and risks for older patients, and they prompt questions about how to pair medication with nutrition, exercise, and social supports to preserve strength while losing fat.
If you care about growing older with independence and vitality, this research connects to those goals. The full article explores who gains the most, what side effects occur, and how these drugs might fit into broader plans for aging well. Follow the link to see how these results could influence care, access, and the future of healthy longevity.
A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health. Participants taking the drug lost over 15% of their body weight on average — far more than those receiving placebo treatment. Many also moved out of obesity categories entirely and reached healthier weight levels.
